PanGen Biotech Inc
KOSDAQ:222110
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PanGen Biotech Inc
KOSDAQ:222110
|
KR |
|
N
|
Nokia Oyj
F:NOAA
|
FI |
Intrinsic Value
The intrinsic value of PanGen Biotech Inc (222110) under the Base Case is 6 168.71 KRW per share. Compared with the current market price of 4 100 KRW, the stock appears Undervalued by 34% .
The intrinsic value is calculated using the DCF method. The model assumes revenue grows about 6% in 2026, then slows: about 1% a year on average over the next five years, less than a third of its five-year pace of 17%. Operating margin ends at 8% by 2033, above its five-year average of -30%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What PanGen Biotech Does
PanGen Biotech makes biological reagents and diagnostic products used in labs, hospitals, and research settings. Its main products include enzymes, molecular biology reagents, and test kits that help customers detect genes, study DNA, and run lab experiments. The company sells these products to diagnostic labs, biotech firms, research institutions, and other life-science customers that need reliable tools for testing and analysis.
- Headquarters
- Korea KR
- Employees
- 75
- IPO date
- Mar 11, 2016
Revenue & Expenses Breakdown
PanGen Biotech Inc
Earnings Waterfall
PanGen Biotech Inc
The intrinsic value for PanGen Biotech Inc (222110) under the Base Case is 6 168.71 KRW.
Compared with the current market price of 4 100 KRW, the stock appears Undervalued by 34% .